Elderly patients are increasingly enrolled in dialysis programs and present a series of special characteristics due to their high morbidity and mortality. Objective: To describe the characteristics of incident dialysis patients aged >75 years, their comorbidities and their admissions, with a view to determining the factors that influence their course and mortality. Patients and Methods: The study included all patients aged >75 years who started dialysis in our center since January 2000. The mean duration of follow-up was 3.3 ± 2.2 years. Data were collected on incident comorbidity, admissions and their causes. A total of 139 patients were included, with a mean age of 78.6 ± 2.6 years (67.6% males, 33.8% diabetic and 7.9% on peritoneal dialysis). Three groups were established according to age: 75–79, 80–85 and >85 years. The most frequent comorbidities were chronic obstructive pulmonary disease (25.9%), ischemic heart disease (25.2%), heart failure (25.9%), neoplasms (23.7%), peripheral vascular disease (23.7%), cerebrovascular disease (18.7%) and arterial hypertension (81%). The Charlson index was calculated, not adjusted for age, and comorbidity tertiles were established. Results: During follow-up, the patients presented 0.82 ± 0.99 admissions/patient/year, with a duration of 12.1 ± 20.6 days/patient/year. The main causes of admission were infection (33%), vascular access problems (27%) and peripheral vascular events (14%). A total of 61 patients died (44%), and 4 underwent kidney transplantation (2.9%). The mean duration of follow-up of the transplanted patients was 3.6 ± 1.8 years. The main causes of death were infection (32%), cardiovascular problems (28.3%) and neoplastic disease (11.3%). The global survival rate was 90, 82 and 53% after 1, 2 and 5 years, respectively. No significant differences in survival or annual admission rate were found in relation to age group and dialysis technique. In contrast, the annual admission rate and days of admission were directly correlated to the Charlson index (p = 0.009 and p = 0.032, respectively). No significant differences in the Charlson index were found between the patients on hemodialysis and those subjected to peritoneal dialysis. In the univariate model, the factors associated to mortality were diabetes, chronic obstructive pulmonary disease, heart failure and the Charlson index. In the multivariate model, only the Charlson index remained as an independent predictive factor (p = 0.006). Conclusions: Unlike the general population, age does not influence mortality or admissions in elderly patients on dialysis. Incident comorbidity is the factor exerting the greatest influence upon mortality and admissions. Advanced age in itself should not be regarded as an excluding factor for starting dialysis.

Keywords:
Elderly, Hemodialysis, Outcomes, Comorbidity, Mortality
1.
Mallick N, El Marasi A: Dialysis in the elderly, to treat or not to treat. Nephrol Dial Traspl 1999;14:37–39.
2.
García López FJ, Robles R, Gentil MA, Lorenzo V, Cleries M, Gracia Blasco MJ, Arrieta J: Grupo de Registros de Enfermos Renales de España: ‘Comparación de la incidencia, prevalencia, modalidades de tratamiento y mortalidad en pacientes con tratamiento renal sustitutivo en cinco comunidades autónomas españolas en el periodo 1991–1996 (in Spanish). Nefrología 1999;19:443–459.
3.
Lorenzo V: ‘Consulta de enfermedad renal crónica avanzada: Experiencia de 12 años’ (in Spanish). Nefrología 2007;27:425–433.
4.
Murtagh F, Marsh J, Donohoe, Ekbal N, Sheerin N, Harris F: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transpl 2007;22:1955–1962.
5.
Chauveau P, Combe C, Laville M, Fouque D, Azar R, Cano N, Canaud B, Roth H, Leverve X, Aparicio M; French Study Group for Nutrition in Dialysis: Factors influencing survival in haemodialysis patients aged older than 75 years: 2.5-year outcome study. Am J Kidney Dis 2001;37:997–1003.
6.
Smith C, Da Silva-Gane M, Chandna S, Warwicker P, Greenwood R, Farrington K: Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract 2003;95:c40–c46.
7.
Kurella M, Covinsky KE, Collins AJ, Chertow GM: Octogenarians and nonagenarians starting dialysis in the United States. Annals Intern Med 2007;146:177–183.
8.
Röhrich B, Asmus G, von Herrath D, Schaefer K: Is it worth performing kidney replacement therapy on patients over 80? Nephrol Dial Transplant 1996;11:2412–2413.
9.
Patel M, Mallick NP, Short CD, et al: Quality of life on haemodialysis in relation to age and co-morbidity. Nephrol Dial Transplant 1996;11:1964–1971.
10.
Munshi SK, Vijayakumar N, Taub NA, Bhullar H, Lo TC, Warwick G: Outcome of renal replacement therapy in the very elderly. Nephrol Dial Transplant 2001;16:128–133.
11.
Lamping DL, Constantinovici N, Roderick P, Normand C, Henderson L, Harris S, et al: Clinical outcomes, quality of life and costs in North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study. Lancet 2000;356:1543–1550.
12.
Chester AC, Rakowski TA, Argy WP, Gicalone A, Schreiner GE: Haemodialysis in the eighth and ninth decades of life. Arch Intern Med 1979;139:1001–1005.
13.
Comité de Registro de la SEN. Informe de de Dialisis y Trasplante de la Sociedad Española de Nefrología y Registros autonómicos correspondientes al año 2007 (in Spanish). www.senefro.org/modules/subsection/files/presentacion_reersen2008.pdf?check_idfile=3559.
14.
ERA-EDTA Registry 2004 Annual Report. Academic Medical Center, Department of Medical Informatics. Amsterdam, The Netherlands, July, 2006.
15.
Garcia-Mendoza M, Valdés C, Ortega T, Rebollo P, Ortega F: Differences in health-related quality of life between elderly and younger patients on hemodialysis. J Nephrol 2006;19:808–818.
16.
Couchoud C, Moranne O, Frimat L, Labeeuw M, Allot V, Stengel B: Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease. Nephrol Dial Transplant 2007;22:3246–3254.
17.
García Cortes MJ, Viedma M, Sánchez Perales MC, Borrego FJ, Pérez Del Barrio P, Gil Cunquero JM, Liebana A, Pérez Bañasco V: Acceso vascular permanente en pacientes de edad avanzada que inician hemodiálisis: ¿Fístula ó catéter? (in Spanish). Nefrología 2005;25:307–314.
18.
Malberti F, Conte F, Limido A, Marcelli D, Spotti D, Lonati F, Locatelli F: Ten years experience of renal replacement treatment in the elderly. Geriatr Nephrol Urol 1997;7:1–10.
19.
Röhrich B, von Herrath D, Asmus G, Schaefer K: The elderly dialysis patient: management of the hospital stay. Nephrol Dial Transplant 1998;13(suppl 7):69–72.
20.
Maiorca R, Vonesh EF, Cavalli P, De Vecchi A, Giangrande A, La Greca G, Scarpioni LL, Bragantini L, Cancarini GC, Cantaluppi A, et al: A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991;11:118–127.
21.
Lunde NM, Port FK, Wolfe RA, Guire KE: Comparison of mortality risk by choice of CAPD versus hemodialysis among elderly patients. Adv Perit Dial 1991;7:68–72.
22.
Debska-Sslizień A, Jankowska MM, Wołyniec W, Zietkiewicz M, Gortowska M, Moszkowska G, Chamienia A, Zadrozny D, Sledziński Z, Rutkowski B: A single-center experience of renal transplantation in elderly patients: a paired-kidney analysis. Transplantation 2007;83:1188–1192.
23.
Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK: Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation 2007;83:1069–1074.
24.
Otero-Raviña F, Rodríguez-Martínez M, Gude F, González-Juanatey JR, Valdés F, Sánchez-Guisande D: Renal transplantation in the elderly: does patient age determine the results? Age Ageing 2005;34:583–587.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.